trial
as of 2026-07-01HCT Effect Among Patients With Psychotic Disorders
NCTId NCT06077279
at a glance
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
120 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2022-11-01
Primary completion
2023-06-30
Eligibility
ALL · 18 Years · 60 Years
Interventions & indications
Sponsors
Alexandria UniversityLead Sponsor
Sites
1 total
Alexandria, Egypt
Facts & assertions
4 sourced
Enrollment
120
Phase
NA
Primary Completion Date
2023-06-30
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
company
indication
indication
indication